| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB100-65535-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB120-6406-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41290-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76290-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43408-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43426-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74486 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65537-0.025mg | |||
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of representative areas of synovial tissue samples taken from patients with end-stage osteoarthritis (OA) or refractory rheumatoid arthritis (RA) is shown. Expression pattern and staining intensity of RA samples represent the stronger intensity of synovial inflammation when compared with OA samples.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0003.jpg "Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of representative areas of synovial tissue samples taken from patients with end-stage osteoarthritis (OA) or refractory rheumatoid arthritis (RA) is shown. Expression pattern and staining intensity of RA samples represent the stronger intensity of synovial inflammation when compared with OA samples.")
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of activation markers in synovial membranes of osteoarthritis. Phenotypic markers that are instrumental in extracellular matrix alteration are detectable only at a low level (MMP-1, CD44v7/8) in areas that are slightly FAP-positive. FAP, fibroblast activation protein; MMP, matrix metalloproteinase.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0001.jpg)
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of activation markers in synovial membranes of rheumatoid arthritis. Expression of fibroblast activation protein (FAP) is accompanied by accumulation of activation markers (MMP-1 and MMP-13) and splice variants of CD44 (v3 and v7/8) that are known to correlate with the degree of inflammation and that are involved in extracellular matrix deposition.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0002.jpg)
![Flow Cytometry: CD45RC Antibody (OX22) [NB120-6406] - Analysis using the FITC conjugate of NB120-6406. Staining of rat spleen cells.](http://images.novusbio.com/fullsize/CD45RC-Antibody-OX22-Flow-Cytometry-NB120-6406-img0004.jpg "Flow Cytometry: CD45RC Antibody (OX22) [NB120-6406] - Analysis using the FITC conjugate of NB120-6406. Staining of rat spleen cells.")
![Flow Cytometry: CD45RC Antibody (OX22) [NB120-6406] - Analysis using the Biotin conjugate of NB120-6406. Staining of rat splenocytes.](http://images.novusbio.com/fullsize/CD45RC-Antibody-OX22-Flow-Cytometry-NB120-6406-img0003.jpg)
![Western Blot: NOX1 Antibody [NBP2-41290] - Western blot analysis of NOX1 in 293 cell lysate with NOX1 antibody at 1 ug/ml.](http://images.novusbio.com/fullsize/NOX1-Antibody-Western-Blot-NBP2-41290-img0001.jpg "Western Blot: NOX1 Antibody [NBP2-41290] - Western blot analysis of NOX1 in 293 cell lysate with NOX1 antibody at 1 ug/ml.")
![Immunohistochemistry: NOX1 Antibody - BSA Free [NBP2-41290] - Immunohistochemistry of NOX1 in human kidney tissue with NOX1 antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41290_rabbit-polyclonal-nox1-antibody-2711202420352499.jpg)
![Immunocytochemistry/ Immunofluorescence: NOX1 Antibody - BSA Free [NBP2-41290] - Immunofluorescence of NOX1 in human kidney tissue with NOX1 antibody at 20 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41290_rabbit-polyclonal-nox1-antibody-2711202420115586.jpg)
![Immunohistochemistry: NLRP7 Antibody - BSA Free [NBP1-76290] - Immunohistochemistry of NLRP7 in human brain tissue with NLRP7 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76290_rabbit-polyclonal-nlrp7-antibody-271120242013188.jpg "Immunohistochemistry: NLRP7 Antibody - BSA Free [NBP1-76290] - Immunohistochemistry of NLRP7 in human brain tissue with NLRP7 antibody at 10 u/mL.")
![Immunocytochemistry/ Immunofluorescence: NLRP7 Antibody - BSA Free [NBP1-76290] - Immunofluorescence of NLRP7 in human brain tissue with NLRP7 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-76290_rabbit-polyclonal-nlrp7-antibody-2711202419353830.jpg)
![Western Blot: NLRP7 Antibody [NBP1-76290] - Analysis of NALP7 in K562 cell lysate with NALP7 antibody at 2 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/NLRP7-Antibody-Western-Blot-NBP1-76290-img0006.jpg)
![Immunohistochemistry-Frozen: B220/CD45R Antibody (HIS24) [NBP1-43408] - Staining of rat splenocytes with 0.5 ug of Mouse IgG2b K Isotype Control FITC (blue histogram) or 0.5 ug of Anti-Rat CD45R (B220) FITC (purple histogram). Cells in the lymphocyte gate were used for analysis (left). Immunohistochemistry of frozen rat spleen using 10 ug/mL Anti-Rat CD45R (B220) FITC (green), 10 ug/mL Anti-Rat Marginal Zone B Cells eFluor 660 (white), and 10 ug/mL Anti-Rat CD3 Biotin followed by 1 ug/mL Streptavidin eFluor (R) 570 (red). Nuclei are stained with DAPI (blue)(right).](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-HIS24-Immunohistochemistry-NBP1-43408-img0004.jpg "Immunohistochemistry-Frozen: B220/CD45R Antibody (HIS24) [NBP1-43408] - Staining of rat splenocytes with 0.5 ug of Mouse IgG2b K Isotype Control FITC (blue histogram) or 0.5 ug of Anti-Rat CD45R (B220) FITC (purple histogram). Cells in the lymphocyte gate were used for analysis (left). Immunohistochemistry of frozen rat spleen using 10 ug/mL Anti-Rat CD45R (B220) FITC (green), 10 ug/mL Anti-Rat Marginal Zone B Cells eFluor 660 (white), and 10 ug/mL Anti-Rat CD3 Biotin followed by 1 ug/mL Streptavidin eFluor (R) 570 (red). Nuclei are stained with DAPI (blue)(right).")
![Flow Cytometry: B220/CD45R Antibody (HIS24) [NBP1-43408] - Analysis using the FITC conjugate of NBP1-43408. Staining of rat splenocytes with 0.05 ug of Mouse IgG2b K Isotype Control FITC (open histogram) or 0.05 ug of Anti-Rat CD45R (B220) FITC (filled histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-HIS24-Flow-Cytometry-NBP1-43408-img0003.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy7 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy7 (open histogram) or Anti-Human CD27 PE-Cy7 (filled histogram). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0011.jpg "Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy7 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy7 (open histogram) or Anti-Human CD27 PE-Cy7 (filled histogram). Cells in the lymphocyte gate were used for analysis.")
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the Allophycocyanin conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control APC (open histogram) or Anti-Human CD27 APC (filled histogram). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0006.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the Biotin conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Anti-Human CD27 PE (left), and APC (right). Appropriate isotype controls were used (open histogram). Cells in the lymphocyte population were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0007.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the FITC conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Anti-Human CD19 APC and Mouse IgG1 K Isotype Control FITC (left) or Anti-Human CD27 FITC (right). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0008.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE conjugate of NBP1-43426. Analysis of human peripheral blood leukocytes using CD27 PE conjugate. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8 cells/test.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0009.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy5 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy5 (open histogram) or 0.25 ug of Anti-Human CD27 PE-Cy5 (filled histogram).=](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0010.jpg)
![Western Blot: TDO2 Antibody (OTI2A4) [NBP2-45995] -Analysis of overexpressedlysates(15ug per lane) from HEK293T cellstransfected with empty plasmid , lane1) , human TDO2 plasmid , lane 2),mouse TDO2 plasmid, lane 3) usinganti-TDO2 antibody (1:500). Figure B,Western blot analysis of the same samples asfigure A with anti-DDK antibody, 1:1000)](http://images.novusbio.com/fullsize/antibody/nbp2-45995_mouse-tdo2-mab-oti2a4-western-blot-342025113045..png "Western Blot: TDO2 Antibody (OTI2A4) [NBP2-45995] -Analysis of overexpressedlysates(15ug per lane) from HEK293T cellstransfected with empty plasmid , lane1) , human TDO2 plasmid , lane 2),mouse TDO2 plasmid, lane 3) usinganti-TDO2 antibody (1:500). Figure B,Western blot analysis of the same samples asfigure A with anti-DDK antibody, 1:1000)")
![Immunohistochemistry-Paraffin: CD59 Antibody (YTH53.1) [NB100-65537] Immunoperoxidase staining of formalin fixed, paraffin embedded human placenta with Rat anti Human CD59](http://images.novusbio.com/fullsize/CD59-Antibody-YTH53-1-Immunohistochemistry-Paraffin-NB100-65537-img0002.jpg "Immunohistochemistry-Paraffin: CD59 Antibody (YTH53.1) [NB100-65537] Immunoperoxidase staining of formalin fixed, paraffin embedded human placenta with Rat anti Human CD59")
![Flow Cytometry: CD59 Antibody (YTH53.1) [NB100-65537] - Staining of human peripheral blood granulocytes with RAT ANTI HUMAN CD59 (NB100-65537).](http://images.novusbio.com/fullsize/CD59-Antibody-YTH53-1-Flow-Cytometry-NB100-65537-img0001.jpg)
![Western Blot: DCXR Antibody [NB100-1068] - (0.1ug/ml) of human kidney lysate (RIPA buffer, 35ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.](http://images.novusbio.com/fullsize/DCXR-Antibody-Western-Blot-NB100-1068-img0002.jpg "Western Blot: DCXR Antibody [NB100-1068] - (0.1ug/ml) of human kidney lysate (RIPA buffer, 35ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.")
![Immunohistochemistry-Paraffin: DCXR Antibody [NB100-1068] - (1ug/ml) staining of paraffin embedded human kidney. Microwaved antigen retrieval with citrate buffer pH 6, HRP-staining.](http://images.novusbio.com/fullsize/DCXR-Antibody-Immunohistochemistry-Paraffin-NB100-1068-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CLEC16A Antibody [NBP1-00171] - Analysis of paraformaldehyde fixed A549 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing strong nuclear and weak cytoplasmic staining. Actin filaments were stained with phalloidin (red) and the nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).](http://images.novusbio.com/fullsize/CLEC16A-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-00171-img0001.jpg "Immunocytochemistry/Immunofluorescence: CLEC16A Antibody [NBP1-00171] - Analysis of paraformaldehyde fixed A549 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing strong nuclear and weak cytoplasmic staining. Actin filaments were stained with phalloidin (red) and the nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).")
![Flow Cytometry: CLEC16A Antibody [NBP1-00171] - Analysis of paraformaldehyde fixed A549 cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (1 ug/mL). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CLEC16A-Antibody-Flow-Cytometry-NBP1-00171-img0002.jpg)
![Western Blot: NKG2D/CD314 Antibody [NB100-1891] - Staining of MOLT-4 cell lysate (A) + peptide (B) with antibody at 0.5 ug/mL (35ug protein in RIPA buffer). Detected by chemiluminescence.](http://images.novusbio.com/fullsize/NKG2D-CD314-Antibody-Western-Blot-NB100-1891-img0001.jpg "Western Blot: NKG2D/CD314 Antibody [NB100-1891] - Staining of MOLT-4 cell lysate (A) + peptide (B) with antibody at 0.5 ug/mL (35ug protein in RIPA buffer). Detected by chemiluminescence.")
![Flow Cytometry: NKG2D/CD314 Antibody [NB100-1891] - Flow cytometric analysis of human peripheral blood monocytes. Primary incubation 30 minutes (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml).](http://images.novusbio.com/fullsize/NKG2D-CD314-Antibody-Flow-Cytometry-NB100-1891-img0002.jpg)
![Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) PE.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-HLy9-25-Flow-Cytometry-NBP1-50070-img0002.jpg "Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) PE.")
![Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) APC.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-HLy9-25-Flow-Cytometry-NBP1-50070-img0001.jpg)
